OCT 16, 2018 10:37 PM PDT

Anti-Venomous Plant Compound

WRITTEN BY: Nouran Amin

According to a study published in PLOS Neglected Tropical Diseases, researchers at the Institute Butantan, São Paulo, Brazil, have discovered a flavonoid found in plants to be effective in acting as antivenom compound from the South American pit viper Bothrops jaraca.

The viper is most commonly found northern Argentina, southern Brazil and northeastern Paraguay. It is an abundant species and the large cause of snakebites. Their venom is composed of a mixture of complex proteins that disrupt chemical reactions inside cells.

Being bitten by the snake, can lead to site swelling, blistering, severe hypotension and systemic bleeding from the skin, nose, and gums--eventually leading to shock, intracranial hemorrhage, or renal failure. More than often, the venom of the viper causes proteolytic, coagulant and hemorrhagic effects. Uniquely, these properties are based on a peptide found in their venom which is presently being used for drug development in the treatment of heart failure and hypertension.

Image via RisingKashmir.com

The flavonoid identified is called ‘rutin’ which can protect envenomed mice from bleeding and inflammation complications. Current anti-venoms can treat the major issues arising from a snake bite however, it cannot treat common saucer implications of the bite including bleeding.

Chemical Structure of Rutin. Image via 'Rutin' from Wikipedia

Existing anti-venoms can treat the major effects of the snake bites however, there are no known therapies for common secondary complications, such as the inability to stop the bleeding.

Results of the research were derived from studies on mouse models injected with both venom and rutin. The mice were than further analyzed for the physiological triggers of venom to better understand the effects rutin on pathophysiological events triggered by the venom. The research findings ‘indicates that rutin has a great potential as an ancillary drug in concert with antivenom therapy to treat snakebites, particularly in countries where antivenom availability is scarce.’

 

Source: Drug Target Review

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
APR 17, 2020
Cannabis Sciences
APR 17, 2020
Does CBD Really Ease Arthritis Pain?
Cannabis products are increasingly used to treat chronic pain from arthritis. As its non psychoactive ingredient, cannab ...
APR 21, 2020
Drug Discovery & Development
APR 21, 2020
Researchers Develop COVID-19 Nasal Spray Vaccine
Researchers from the University of Waterloo in Canada are working on a DNA-based vaccine for COVID-19 that can be applie ...
APR 23, 2020
Drug Discovery & Development
APR 23, 2020
Over 200 Volunteers Design $216 Ventilator for COVID-19
Over 200 volunteers from France have designed a ventilator suitable to treat COVID-19 patients that costs less than $500 ...
APR 23, 2020
Cancer
APR 23, 2020
Doctors, watch out for unexpected side effects in small clinical trials
Doctors who have patients in small-sized clinical trials that test new cancer drugs should be on the look-out for unexpe ...
APR 24, 2020
Drug Discovery & Development
APR 24, 2020
Drug Targets Hard To Treat Uterine Cancer
A clinical trial was deemed successful when evaluating a therapeutic for a hard-to-treat form of uterine cancer. The dru ...
APR 30, 2020
Drug Discovery & Development
APR 30, 2020
FDA to Approve Remdesivir to Fight COVID-19
A clinical trial investigating the ability of antiviral drug remdesivir to treat COVID-19 has found that it can signific ...
Loading Comments...